Neuland Laboratories has informed that a meeting of the Board of Directors of the Company will be held on August 27, 2016, to consider a proposal to merge Neuland Health Sciences (Holding Company) (NHSPL) and Neuland Pharma Research (subsidiary of NHSPL) (NPRPL) with Neuland Laboratories. Further, as per the provisions of the Insider Trading Code of the Company, the Trading Window for transactions in the shares of the Company is closed from August 24, 2016 to August 29, 2016 and will be reopened on August 30, 2016 for the aforementioned purpose.
The above information is a part of company’s filings submitted to BSE.
